Rs6604026
From SNPedia
| is a | snp |
| is | mentioned by |
| dbSNP | rs6604026 |
| nextbio | rs6604026 |
| hapmap | rs6604026 |
| 1000 genomes | rs6604026 |
| hgdp | rs6604026 |
| ensembl | rs6604026 |
| gopubmed | rs6604026 |
| scholar | rs6604026 |
| rs6604026 | |
| pharmgkb | rs6604026 |
| gwascentral | rs6604026 |
| openSNP | rs6604026 |
| 23andMe | rs6604026 |
| 23andMe all | rs6604026 |
| SNP Nexus | |
| SNPshot | rs6604026 |
| SNPdbe | rs6604026 |
| MSV3d | rs6604026 |
| Gene | RPL5 |
| Chromosome | 1 |
| Orientation | plus |
| Position | 93303603 |
| Reference | GRCh37 37.1/131 |
| Max Magnitude | 2 |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 2 | >1.15x risk |
| (C;T) | 1.15x risk | |
| (T;T) | 0 | common |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
The risk allele (oriented to the dbSNP entry) is (C); the odds ratio associated with this allele is 1.15 (CI 1.08-1.22). [PMID 17660530]
| GWAS | |
|---|---|
| SNP | rs6604026 |
| PubMedID | [PMID 17660530] |
| Condition | Multiple sclerosis |
| Gene | RPL5 |
| Risk Allele | C |
| pValue | 8.00E-006 |
| OR | 1.15 |
| 95% CI | 1.08-1.22 |
| GWAS snp | |
|---|---|
| PMID | [PMID 19525955] |
| Trait | Multiple sclerosis |
| Title | Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 |
| Risk Allele | G |
| P-val | 0.000003 |
| Odds Ratio | 1.17 [NR] |
[PMID 18650830] Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians
| PharmGKB | PA162356685 |
| Name | |
| Annotation | GWAS Results: Risk alleles for multiple sclerosis identified by a genomewide study (Initial Sample Size: 931 trios, 2,431 controls; Replication Sample Size: 609 trios, 2,322 cases, 2,987 controls; Risk Allele: rs6604026-C). |
| Gene | RPL5, SNORD21, FAM69A, SNORA66 |
| Featue | |
| Evidence | PubMed ID:17660530; Web Resource:http://www.genome.gov/gwastudies/ |
| Drugs | |
| Diseases | Multiple Sclerosis |
| Curation Level | Non-Curated |
| PharmGKB | PA162356162 |
| Name | |
| Annotation | In a replicated GWAS of U.K. and U.S. case/parent trios, this variant was shown to be associated with multiple sclerosis risk. |
| Gene | RPL5, SNORD21, FAM69A, SNORA66 |
| Featue | |
| Evidence | PubMed ID:17660530 |
| Drugs | |
| Diseases | Multiple Sclerosis |
| Curation Level | Curated |